Prescription Drug Monitoring Programs (PDMPs) are widely available, but not yet uniformly used. A clinical pharmacist and associate professor evaluates the current landscape, and what can be improved to enhance their utility in curbing substance misuse and abuse.
Did you enjoy this article?
Subscribe to the PAINWeek Newsletter
and get our latest articles and more direct to your inbox